Answers are grounded in this paper and cite their sources.
Glycoengineering: This review highlights the application of structure-based enzyme engineering toward enhancing the promiscuity of nucleotidylytransferases (such as Ep, whose active site is shown here) and glycosyltransferases, which are essential to the in vitro glycorandomization (IVG) strategy. IVG is a versatile strategy with great potential for the generation of novel therapeutics as illustrated by the preparation of a library of diversified vancomycin analogues.
No takes yet. Share an insight, caveat, or question.
Thorson et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: